Case Report: Infantile-Onset Fulminant Type 1 Diabetes Mellitus Caused by Novel Compound Heterozygous LRBA Variants
Lipopolysaccharide-responsive beige-like anchor (LRBA) deficiency is a subtype of common variable immune deficiency (CVID). Numerous case reports and cohort studies have described a broad spectrum of clinical manifestations and variable disease phenotypes, including immune dysregulation, enteropathy...
Gespeichert in:
Veröffentlicht in: | Frontiers in immunology 2021-04, Vol.12, p.677572 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | 677572 |
container_title | Frontiers in immunology |
container_volume | 12 |
creator | Totsune, Eriko Nakano, Tomohiro Moriya, Kunihiko Sato, Daichi Suzuki, Dai Miura, Akinobu Katayama, Saori Niizuma, Hidetaka Kanno, Junko van Zelm, Menno C Imai, Kohsuke Kanegane, Hirokazu Sasahara, Yoji Kure, Shigeo |
description | Lipopolysaccharide-responsive beige-like anchor (LRBA) deficiency is a subtype of common variable immune deficiency (CVID). Numerous case reports and cohort studies have described a broad spectrum of clinical manifestations and variable disease phenotypes, including immune dysregulation, enteropathy, and recurrent infections. Although LRBA deficiency is an autosomal recessive primary immunodeficiency resulting in a phenotype similar to CVID, it is a monogenic disease and separate from CVID. Recently, in a report of monogenic primary immunodeficiency disorder associated with CVID and autoimmunity, the most common mutated gene was
. We report the case of a girl who presented with fulminant type 1 diabetes at age 7 months. She later experienced recurrent bacterial infections with neutropenia and idiopathic thrombocytopenic purpura. Clinical genome sequencing revealed compound heterozygosity of the
gene, which bore two novel mutations. A genetic basis should be considered in the differential diagnosis for very young patients with fulminant autoimmunity, and the diagnostic work-up should include evaluation of markers of immunodeficiency. |
doi_str_mv | 10.3389/fimmu.2021.677572 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_doaj_</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8072023</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_9715a48c5f38436bbd65b95756762c07</doaj_id><sourcerecordid>33912197</sourcerecordid><originalsourceid>FETCH-LOGICAL-c498t-5a82ed825daaae62c6a504c114b7f1613cec1985c7d5aba034ea0e503b2c157b3</originalsourceid><addsrcrecordid>eNpVkc9O3DAQh6OqqCDgAXqp_ALZ-k8cJz1UoqHAStsiIdqrNXYmW6MkjuwEaXl6DEsRzMWj8fy-OXxZ9pnRlRBV_bVzw7CsOOVsVSolFf-QHbGyLHLBefHxTX-YncZ4R1MVtRBCfsoOhagZZ7U6ymIDEckNTj7M38h67GCcXY_59RhxJhdLP7gxjcjtbkLCyLkDgzNG8gv73s1LJA0sEVtiduS3v8eeNH6Y_DK25CrtBf-w2_q0tbn5cUb-QnCJFU-ygw76iKcv73H25-LnbXOVb64v183ZJrdFXc25hIpjW3HZAgCW3JYgaWEZK4zqWMmERcvqSlrVSjBARYFAUVJhuGVSGXGcrffc1sOdnoIbIOy0B6efBz5sNYTZ2R51rZiEorKyE1UhSmPaUppaKlmqdJiqxPq-Z02LGbC1OM4B-nfQ9z-j-6e3_l5XVCVHIgHYHmCDjzFg95plVD8J1c9C9ZNQvReaMl_eHn1N_NcnHgEIIZ5s</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Case Report: Infantile-Onset Fulminant Type 1 Diabetes Mellitus Caused by Novel Compound Heterozygous LRBA Variants</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Totsune, Eriko ; Nakano, Tomohiro ; Moriya, Kunihiko ; Sato, Daichi ; Suzuki, Dai ; Miura, Akinobu ; Katayama, Saori ; Niizuma, Hidetaka ; Kanno, Junko ; van Zelm, Menno C ; Imai, Kohsuke ; Kanegane, Hirokazu ; Sasahara, Yoji ; Kure, Shigeo</creator><creatorcontrib>Totsune, Eriko ; Nakano, Tomohiro ; Moriya, Kunihiko ; Sato, Daichi ; Suzuki, Dai ; Miura, Akinobu ; Katayama, Saori ; Niizuma, Hidetaka ; Kanno, Junko ; van Zelm, Menno C ; Imai, Kohsuke ; Kanegane, Hirokazu ; Sasahara, Yoji ; Kure, Shigeo</creatorcontrib><description>Lipopolysaccharide-responsive beige-like anchor (LRBA) deficiency is a subtype of common variable immune deficiency (CVID). Numerous case reports and cohort studies have described a broad spectrum of clinical manifestations and variable disease phenotypes, including immune dysregulation, enteropathy, and recurrent infections. Although LRBA deficiency is an autosomal recessive primary immunodeficiency resulting in a phenotype similar to CVID, it is a monogenic disease and separate from CVID. Recently, in a report of monogenic primary immunodeficiency disorder associated with CVID and autoimmunity, the most common mutated gene was
. We report the case of a girl who presented with fulminant type 1 diabetes at age 7 months. She later experienced recurrent bacterial infections with neutropenia and idiopathic thrombocytopenic purpura. Clinical genome sequencing revealed compound heterozygosity of the
gene, which bore two novel mutations. A genetic basis should be considered in the differential diagnosis for very young patients with fulminant autoimmunity, and the diagnostic work-up should include evaluation of markers of immunodeficiency.</description><identifier>ISSN: 1664-3224</identifier><identifier>EISSN: 1664-3224</identifier><identifier>DOI: 10.3389/fimmu.2021.677572</identifier><identifier>PMID: 33912197</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>CTLA-4 deficiency ; Immunology ; infantile-onset fulminant type 1 diabetes mellitus ; LRBA deficiency ; refractory autoimmune cytopenia ; transposable elements (TE)</subject><ispartof>Frontiers in immunology, 2021-04, Vol.12, p.677572</ispartof><rights>Copyright © 2021 Totsune, Nakano, Moriya, Sato, Suzuki, Miura, Katayama, Niizuma, Kanno, van Zelm, Imai, Kanegane, Sasahara and Kure.</rights><rights>Copyright © 2021 Totsune, Nakano, Moriya, Sato, Suzuki, Miura, Katayama, Niizuma, Kanno, van Zelm, Imai, Kanegane, Sasahara and Kure 2021 Totsune, Nakano, Moriya, Sato, Suzuki, Miura, Katayama, Niizuma, Kanno, van Zelm, Imai, Kanegane, Sasahara and Kure</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c498t-5a82ed825daaae62c6a504c114b7f1613cec1985c7d5aba034ea0e503b2c157b3</citedby><cites>FETCH-LOGICAL-c498t-5a82ed825daaae62c6a504c114b7f1613cec1985c7d5aba034ea0e503b2c157b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072023/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072023/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33912197$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Totsune, Eriko</creatorcontrib><creatorcontrib>Nakano, Tomohiro</creatorcontrib><creatorcontrib>Moriya, Kunihiko</creatorcontrib><creatorcontrib>Sato, Daichi</creatorcontrib><creatorcontrib>Suzuki, Dai</creatorcontrib><creatorcontrib>Miura, Akinobu</creatorcontrib><creatorcontrib>Katayama, Saori</creatorcontrib><creatorcontrib>Niizuma, Hidetaka</creatorcontrib><creatorcontrib>Kanno, Junko</creatorcontrib><creatorcontrib>van Zelm, Menno C</creatorcontrib><creatorcontrib>Imai, Kohsuke</creatorcontrib><creatorcontrib>Kanegane, Hirokazu</creatorcontrib><creatorcontrib>Sasahara, Yoji</creatorcontrib><creatorcontrib>Kure, Shigeo</creatorcontrib><title>Case Report: Infantile-Onset Fulminant Type 1 Diabetes Mellitus Caused by Novel Compound Heterozygous LRBA Variants</title><title>Frontiers in immunology</title><addtitle>Front Immunol</addtitle><description>Lipopolysaccharide-responsive beige-like anchor (LRBA) deficiency is a subtype of common variable immune deficiency (CVID). Numerous case reports and cohort studies have described a broad spectrum of clinical manifestations and variable disease phenotypes, including immune dysregulation, enteropathy, and recurrent infections. Although LRBA deficiency is an autosomal recessive primary immunodeficiency resulting in a phenotype similar to CVID, it is a monogenic disease and separate from CVID. Recently, in a report of monogenic primary immunodeficiency disorder associated with CVID and autoimmunity, the most common mutated gene was
. We report the case of a girl who presented with fulminant type 1 diabetes at age 7 months. She later experienced recurrent bacterial infections with neutropenia and idiopathic thrombocytopenic purpura. Clinical genome sequencing revealed compound heterozygosity of the
gene, which bore two novel mutations. A genetic basis should be considered in the differential diagnosis for very young patients with fulminant autoimmunity, and the diagnostic work-up should include evaluation of markers of immunodeficiency.</description><subject>CTLA-4 deficiency</subject><subject>Immunology</subject><subject>infantile-onset fulminant type 1 diabetes mellitus</subject><subject>LRBA deficiency</subject><subject>refractory autoimmune cytopenia</subject><subject>transposable elements (TE)</subject><issn>1664-3224</issn><issn>1664-3224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkc9O3DAQh6OqqCDgAXqp_ALZ-k8cJz1UoqHAStsiIdqrNXYmW6MkjuwEaXl6DEsRzMWj8fy-OXxZ9pnRlRBV_bVzw7CsOOVsVSolFf-QHbGyLHLBefHxTX-YncZ4R1MVtRBCfsoOhagZZ7U6ymIDEckNTj7M38h67GCcXY_59RhxJhdLP7gxjcjtbkLCyLkDgzNG8gv73s1LJA0sEVtiduS3v8eeNH6Y_DK25CrtBf-w2_q0tbn5cUb-QnCJFU-ygw76iKcv73H25-LnbXOVb64v183ZJrdFXc25hIpjW3HZAgCW3JYgaWEZK4zqWMmERcvqSlrVSjBARYFAUVJhuGVSGXGcrffc1sOdnoIbIOy0B6efBz5sNYTZ2R51rZiEorKyE1UhSmPaUppaKlmqdJiqxPq-Z02LGbC1OM4B-nfQ9z-j-6e3_l5XVCVHIgHYHmCDjzFg95plVD8J1c9C9ZNQvReaMl_eHn1N_NcnHgEIIZ5s</recordid><startdate>20210412</startdate><enddate>20210412</enddate><creator>Totsune, Eriko</creator><creator>Nakano, Tomohiro</creator><creator>Moriya, Kunihiko</creator><creator>Sato, Daichi</creator><creator>Suzuki, Dai</creator><creator>Miura, Akinobu</creator><creator>Katayama, Saori</creator><creator>Niizuma, Hidetaka</creator><creator>Kanno, Junko</creator><creator>van Zelm, Menno C</creator><creator>Imai, Kohsuke</creator><creator>Kanegane, Hirokazu</creator><creator>Sasahara, Yoji</creator><creator>Kure, Shigeo</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20210412</creationdate><title>Case Report: Infantile-Onset Fulminant Type 1 Diabetes Mellitus Caused by Novel Compound Heterozygous LRBA Variants</title><author>Totsune, Eriko ; Nakano, Tomohiro ; Moriya, Kunihiko ; Sato, Daichi ; Suzuki, Dai ; Miura, Akinobu ; Katayama, Saori ; Niizuma, Hidetaka ; Kanno, Junko ; van Zelm, Menno C ; Imai, Kohsuke ; Kanegane, Hirokazu ; Sasahara, Yoji ; Kure, Shigeo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c498t-5a82ed825daaae62c6a504c114b7f1613cec1985c7d5aba034ea0e503b2c157b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>CTLA-4 deficiency</topic><topic>Immunology</topic><topic>infantile-onset fulminant type 1 diabetes mellitus</topic><topic>LRBA deficiency</topic><topic>refractory autoimmune cytopenia</topic><topic>transposable elements (TE)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Totsune, Eriko</creatorcontrib><creatorcontrib>Nakano, Tomohiro</creatorcontrib><creatorcontrib>Moriya, Kunihiko</creatorcontrib><creatorcontrib>Sato, Daichi</creatorcontrib><creatorcontrib>Suzuki, Dai</creatorcontrib><creatorcontrib>Miura, Akinobu</creatorcontrib><creatorcontrib>Katayama, Saori</creatorcontrib><creatorcontrib>Niizuma, Hidetaka</creatorcontrib><creatorcontrib>Kanno, Junko</creatorcontrib><creatorcontrib>van Zelm, Menno C</creatorcontrib><creatorcontrib>Imai, Kohsuke</creatorcontrib><creatorcontrib>Kanegane, Hirokazu</creatorcontrib><creatorcontrib>Sasahara, Yoji</creatorcontrib><creatorcontrib>Kure, Shigeo</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Totsune, Eriko</au><au>Nakano, Tomohiro</au><au>Moriya, Kunihiko</au><au>Sato, Daichi</au><au>Suzuki, Dai</au><au>Miura, Akinobu</au><au>Katayama, Saori</au><au>Niizuma, Hidetaka</au><au>Kanno, Junko</au><au>van Zelm, Menno C</au><au>Imai, Kohsuke</au><au>Kanegane, Hirokazu</au><au>Sasahara, Yoji</au><au>Kure, Shigeo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Case Report: Infantile-Onset Fulminant Type 1 Diabetes Mellitus Caused by Novel Compound Heterozygous LRBA Variants</atitle><jtitle>Frontiers in immunology</jtitle><addtitle>Front Immunol</addtitle><date>2021-04-12</date><risdate>2021</risdate><volume>12</volume><spage>677572</spage><pages>677572-</pages><issn>1664-3224</issn><eissn>1664-3224</eissn><abstract>Lipopolysaccharide-responsive beige-like anchor (LRBA) deficiency is a subtype of common variable immune deficiency (CVID). Numerous case reports and cohort studies have described a broad spectrum of clinical manifestations and variable disease phenotypes, including immune dysregulation, enteropathy, and recurrent infections. Although LRBA deficiency is an autosomal recessive primary immunodeficiency resulting in a phenotype similar to CVID, it is a monogenic disease and separate from CVID. Recently, in a report of monogenic primary immunodeficiency disorder associated with CVID and autoimmunity, the most common mutated gene was
. We report the case of a girl who presented with fulminant type 1 diabetes at age 7 months. She later experienced recurrent bacterial infections with neutropenia and idiopathic thrombocytopenic purpura. Clinical genome sequencing revealed compound heterozygosity of the
gene, which bore two novel mutations. A genetic basis should be considered in the differential diagnosis for very young patients with fulminant autoimmunity, and the diagnostic work-up should include evaluation of markers of immunodeficiency.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>33912197</pmid><doi>10.3389/fimmu.2021.677572</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1664-3224 |
ispartof | Frontiers in immunology, 2021-04, Vol.12, p.677572 |
issn | 1664-3224 1664-3224 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8072023 |
source | DOAJ Directory of Open Access Journals; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | CTLA-4 deficiency Immunology infantile-onset fulminant type 1 diabetes mellitus LRBA deficiency refractory autoimmune cytopenia transposable elements (TE) |
title | Case Report: Infantile-Onset Fulminant Type 1 Diabetes Mellitus Caused by Novel Compound Heterozygous LRBA Variants |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T10%3A56%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Case%20Report:%20Infantile-Onset%20Fulminant%20Type%201%20Diabetes%20Mellitus%20Caused%20by%20Novel%20Compound%20Heterozygous%20LRBA%20Variants&rft.jtitle=Frontiers%20in%20immunology&rft.au=Totsune,%20Eriko&rft.date=2021-04-12&rft.volume=12&rft.spage=677572&rft.pages=677572-&rft.issn=1664-3224&rft.eissn=1664-3224&rft_id=info:doi/10.3389/fimmu.2021.677572&rft_dat=%3Cpubmed_doaj_%3E33912197%3C/pubmed_doaj_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/33912197&rft_doaj_id=oai_doaj_org_article_9715a48c5f38436bbd65b95756762c07&rfr_iscdi=true |